Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2019 | 08-2018 | 08-2017 | 12-2016 | 08-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,172 | -2,344 | -235 | N/A | -30 |
| Depreciation Amortization | 1 | 0 | 1 | 0 | N/A |
| Other Working Capital | -140 | 443 | 14 | -3 | 11 |
| Other Operating Activity | -481 | 290 | 3 | 0 | 0 |
| Operating Cash Flow | $-2,793 | $-1,610 | $-217 | $-3 | $-19 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | N/A | 0 | N/A |
| Purchase Sale Intangibles | -1,500 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,500 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,501 | $-1 | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 29 | N/A | N/A |
| Common Stock Issued | 8,376 | 1,387 | 773 | N/A | N/A |
| Other Financing Activity | 1 | 2 | -17 | 0 | 5 |
| Financing Cash Flow | $8,377 | $1,389 | $785 | $N/A | $5 |
| Exchange Rate Effect | 3 | -13 | 1 | 0 | N/A |
| Beginning Cash Position | 337 | 573 | 4 | N/A | 17 |
| End Cash Position | 4,424 | 337 | 572 | N/A | 4 |
| Net Cash Flow | $4,087 | $-235 | $569 | $-3 | $-13 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,793 | -1,610 | -217 | -3 | -19 |
| Capital Expenditure | -1 | -1 | N/A | N/A | N/A |
| Free Cash Flow | -2,793 | -1,611 | -217 | -3 | -19 |